CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

This is an archived document. The links are no longer being updated.

TB Notes 3, 2002

New CDC Publications

Bock NN, Sterling TR, Hamilton CD, Pachucki C, Wang YC, Conwell DS, Mosher A, Samuels M, and Vernon A. A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment. Am J Respir Crit Care Med 2002 Jun 1; 165 (11): 1526-30.

CDC. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens. [Notice to readers.] MMWR 2002;51(10):214-215.

CDC. Guidelines for preventing opportunistic infections among HIV-infected persons 2002. MMWR 2002; 51 (No. RR-8).

CDC. Progress toward TB control India, 2001. MMWR 2002;51(11):229-232.

CDC. Progressing toward tuberculosis elimination in low-incidence areas of the United States. MMWR 2002;51(No. RR-5).

CDC. Tuberculosis morbidity among U.S.-born and foreign-born populations United States, 2000. MMWR 2002;51(5):101-104.

CDC. Tuberculosis outbreak on an American Indian reservation Montana, 2000-2001. MMWR 2002;51(11):232-234.

CDC. World TB Day March 24, 2002. [Box.] MMWR 2002;51(11).

Fitzpatrick LK, Okwera A, Mugerwa R, Ridzon R, Ehiner J, and Onorato I. An investigation of suspected exogenous reinfection in tuberculosis patients in Kampala, Uganda. Int J Tuberc Lung Dis 2002 Jun; 6 (6): 550-2.

Reichler MR, Reves R, Bur S, Ford J, Thompson V, Mangura B, Onorato IM, Valway SE, for the Contact Investigation Study Group. Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States. Southern Medical Journal 2002; 95 (4): 414-420.

Reichler M, Taylor Z, Castro KG. Factors in tuberculosis contact investigations. [Letter to the editor.] JAMA 2002; 287 (22):2944-45.

Saraiya M, Cookson ST, Tribble P, Silk B, Cass R, Poonja S, Walting M, Howland N, Paz EA, Cochran J, Moser KS, Oxtoby MJ, Binkin NJ. Tuberculosis screening among foreign-born persons applying for permanent US residence. Am J Public Health 2002; 92(5): 826-829.

The Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 2002; 360: 528-34.

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333